Merck & Co., Inc. is a major biopharmaceutical company that develops, makes, and sells prescription medicines. Its filings show it lobbies Congress on Medicare and Medicaid rules (like Part B and Part D reimbursement and drug pricing programs), patent and innovation policies (including Bayh-Dole march-in rights), FDA and health care coverage issues, and trade and tax matters affecting the drug supply and pricing.
Show the dominant industry call, how mixed the client looks, and the allocation across the top labeled sectors.
Annual totals based on disclosed filing amounts.
Issue rankings are based on disclosed activity mentions, with filing amounts apportioned evenly across issues within the same filing.
The lobbying registrants handling this client, ranked by disclosed filing amounts.
Lobbyists are ranked by appearances and an equal share of each filing's reported amount.
BRITTANY JOHNSON HERNANDEZ
The latest disclosures for this client.
CROSSROADS STRATEGIES, LLC
Q2CROSSROADS STRATEGIES, LLC
Q1The entities named in disclosed activities are the clearest available signal for where the client is aiming attention.
CROSSROADS STRATEGIES, LLC
JASON BENJAMIN VAN PELT
CROSSROADS STRATEGIES, LLC
MATHEW LAPINSKI
CROSSROADS STRATEGIES, LLC
ms CHERYL LYNN JAEGER
CROSSROADS STRATEGIES, LLC
mr STEPHEN THOMAS VOLJAVEC
CROSSROADS STRATEGIES, LLC
JOHN GREEN
CROSSROADS STRATEGIES, LLC
JASON GLEASON
CROSSROADS STRATEGIES, LLC
CROSSROADS STRATEGIES, LLC
Q4CROSSROADS STRATEGIES, LLC
Q3CROSSROADS STRATEGIES, LLC
Q2CROSSROADS STRATEGIES, LLC
Q1